NBY NovaBay Pharmaceuticals, Inc.

NYSE novabay.com


$ 1.07 $ 0.01 (0.94 %)    

Wednesday, 12-Nov-2025 10:52:51 EST
QQQ $ 619.14 $ -5.64 (-0.9 %)
DIA $ 482.84 $ 2.28 (0.47 %)
SPY $ 681.95 $ -2.84 (-0.41 %)
TLT $ 90.14 $ 0.19 (0.21 %)
GLD $ 384.70 $ 4.55 (1.2 %)
$ 1.07
$ 1.06
$ 1.06 x 1,244
$ 1.07 x 100
$ 1.06 - $ 1.07
$ 0.30 - $ 2.93
200,371
na
134.83M
$ 1.36
$ 41.58
TBD
na
na ($ 0.75)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 04-02-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-26-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-31-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-29-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-25-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 03-26-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 03-29-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-21-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 08-10-2017 06-30-2017 10-Q
35 05-11-2017 03-31-2017 10-Q
36 03-23-2017 12-31-2016 10-K
37 11-10-2016 09-30-2016 10-Q
38 08-11-2016 06-30-2016 10-Q
39 05-12-2016 03-31-2016 10-Q
40 03-04-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 novabay-pharmaceuticals-appoints-michael-kazley-as-ceo-and-chairman

- SEC Filing

 novabay-pharmaceuticals-david-lazar-resigns-as-ceo

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001389545/000182912625007992/novabay_8k.htm

 novabay-pharmaceuticals-files-for-mixed-shelf-of-up-to-200m

-SEC Filing

Core News & Articles

Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION